G. Xu

9.2k total citations
10 papers, 99 citations indexed

About

G. Xu is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, G. Xu has authored 10 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Hematology. Recurrent topics in G. Xu's work include Acute Lymphoblastic Leukemia research (2 papers), Cancer-related Molecular Pathways (2 papers) and Immune Cell Function and Interaction (2 papers). G. Xu is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Cancer-related Molecular Pathways (2 papers) and Immune Cell Function and Interaction (2 papers). G. Xu collaborates with scholars based in China and United States. G. Xu's co-authors include Yongzhao Yao, Jun Gao, Fei Liu, Yiqi Du, Yu Bai, Richard Wu, Zhangdong Jin, Xiaobei Zhan, Wenjun Zhang and Meiyu Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Journal of Cellular and Molecular Medicine.

In The Last Decade

G. Xu

10 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Xu China	5	57	34	24	18	16	10	99
Robert S. Sandler United States	4	49 0.9×	41 1.2×	10 0.4×	19 1.1×	23 1.4×	6	114
William Carlos Nahas Brazil	6	71 1.2×	12 0.4×	47 2.0×	18 1.0×	24 1.5×	20	128
Jyoti Sharma India	6	58 1.0×	22 0.6×	52 2.2×	17 0.9×	27 1.7×	29	108
Johanna Falkenhorst Germany	5	12 0.2×	34 1.0×	37 1.5×	17 0.9×	18 1.1×	13	69
Lucia Duinhouwer Netherlands	7	41 0.7×	7 0.2×	6 0.3×	13 0.7×	8 0.5×	8	79
Cunchuan Wang China	7	42 0.7×	12 0.4×	51 2.1×	26 1.4×	18 1.1×	17	114
Sree B. Chalasani United States	6	24 0.4×	6 0.2×	26 1.1×	21 1.2×	38 2.4×	15	84
Zsolt Faluhelyi Hungary	4	15 0.3×	25 0.7×	17 0.7×	35 1.9×	19 1.2×	4	81
Jay Anderson United States	6	55 1.0×	11 0.3×	15 0.6×	9 0.5×	44 2.8×	14	121
Miriam Ahlborn Germany	4	20 0.4×	16 0.5×	59 2.5×	11 0.6×	57 3.6×	6	94

Countries citing papers authored by G. Xu

Since Specialization

Citations

This map shows the geographic impact of G. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Xu more than expected).

Fields of papers citing papers by G. Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Xu. The network helps show where G. Xu may publish in the future.

Co-authorship network of co-authors of G. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of G. Xu. A scholar is included among the top collaborators of G. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Xu. G. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Xu, G., Zhao Zeng, Zhibo Zhang, et al.. (2024). The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph‐like ALL. Journal of Cellular and Molecular Medicine. 28(3). e18114–e18114. 2 indexed citations

Xu, G., et al.. (2024). DYRK2 controls GSTPI expression through ubiquitination and degradation of Twist1 to reduce chemotherapy resistance caused by EMT in breast cancer. Journal of Molecular Histology. 56(1). 35–35. 1 indexed citations

Zhang, Xiaomei, Yi Liu, Jun Li, et al.. (2024). How can we establish animal models of HIV‐associated lymphoma?. SHILAP Revista de lepidopterología. 7(4). 484–496. 2 indexed citations

Fu, Xiao‐Yuan, Cancan Wang, Yanyan Li, et al.. (2022). Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export. Frontiers in Oncology. 12. 899927–899927. 3 indexed citations

Xu, G., Limin Liu, Man Wang, et al.. (2022). Treatments of Ph-like acute lymphoblastic leukemia: a real-world retrospective analysis from a single large center in China. Leukemia & lymphoma. 63(11). 2652–2662. 6 indexed citations

Liu, Limin, G. Xu, Yanming Zhang, et al.. (2020). Comparison of 2 Different Rabbit Anti-Thymocyte Globulin (r-ATG) Preparations: Thymocyte r-ATG versus T Lymphoblast Cell Line r-ATG in Allogeneic Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia: Propensity Score-Matched Analysis. Transplantation and Cellular Therapy. 27(2). 186.e1–186.e3. 6 indexed citations

Wang, Wei, Yishu Liu, Yanyan Li, et al.. (2018). ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway. International Journal of Oncology. 53(5). 2102–2110. 14 indexed citations

Xu, G., et al.. (2012). [The immune effects of rituximab on dendritic cells derived from patients with primary immune thrombocytopenia].. PubMed. 33(3). 207–10. 5 indexed citations

Bai, Yu, Richard Wu, Yongzhao Yao, et al.. (2010). Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102 665 patients from 1996 to 2006. Gut. 59(6). 722–728. 58 indexed citations

10.

Matzner, William, et al.. (1995). A Comparison of Flow Cytometry and Microcytotoxicity for the Evaluation of Alloimmune Therapy in Patients With Recurrent Spontaneous Abortions. American Journal of Reproductive Immunology. 33(1). 10–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact